(PM) Philip Morris International - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7181721090
Stock: Cigarettes, Heat-Not-Burn, E-Vapor, Oral Nicotine, Accessories
Total Rating 60
Risk 77
Buy Signal -0.32
| Risk 5d forecast | |
|---|---|
| Volatility | 26.9% |
| Relative Tail Risk | -7.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 16.15 |
| Character TTM | |
|---|---|
| Beta | -0.218 |
| Beta Downside | 0.255 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.64% |
| CAGR/Max DD | 1.32 |
EPS (Earnings per Share)
Revenue
Description: PM Philip Morris International March 02, 2026
Philip Morris International Inc. (NYSE: PM) is a global tobacco firm that sells traditional cigarettes and a growing portfolio of smoke-free products-including heat-not-burn IQOS, e-vapor VEEV, and oral nicotine ZYN-alongside consumer accessories and wellness items. The company, incorporated in 1987, is headquartered in Stamford, Connecticut, and operates under the GICS Tobacco sub-industry.
Recent performance highlights include FY 2023 net revenue of $29.7 billion, a 4% year-over-year increase driven largely by a 12% rise in IQOS sales and a 15% jump in ZYN volumes. Adjusted earnings per share reached $6.00, reflecting improved margins as the firm shifts toward higher-margin reduced-risk products. Key sector drivers remain tightening regulatory environments and a consumer pivot toward reduced-risk alternatives, while macro-economic pressures such as inflation and discretionary spending trends continue to shape demand.
For a deeper dive, check out ValueRay’s analysis.
Headlines to watch out for
- IQOS heat-not-burn product sales drive revenue growth
- Cigarette volume declines impact traditional revenue
- Regulatory restrictions on tobacco products increase compliance costs
- Currency fluctuations affect international earnings
- Excise taxes on tobacco products reduce profitability
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 11.50b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -2.02 > 1.0 |
| NWC/Revenue: -2.62% < 20% (prev -7.25%; Δ 4.63% < -1%) |
| CFO/TA 0.18 > 3% & CFO 12.23b > Net Income 11.50b |
| Net Debt (43.96b) to EBITDA (17.08b): 2.57 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.50b) vs 12m ago -3.32% < -2% |
| Gross Margin: 66.42% > 18% (prev 0.65%; Δ 6577 % > 0.5%) |
| Asset Turnover: 61.99% > 50% (prev 61.31%; Δ 0.69% > 0%) |
| Interest Coverage Ratio: 11.75 > 6 (EBITDA TTM 17.08b / Interest Expense TTM 1.30b) |
Altman Z'' 3.45
| A: -0.02 (Total Current Assets 24.36b - Total Current Liabilities 25.43b) / Total Assets 69.19b |
| B: 0.51 (Retained Earnings 35.40b / Total Assets 69.19b) |
| C: 0.23 (EBIT TTM 15.25b / Avg Total Assets 65.48b) |
| D: 0.30 (Book Value of Equity 23.10b / Total Liabilities 77.21b) |
| Altman-Z'' Score: 3.45 = A |
Beneish M -2.92
| DSRI: 1.16 (Receivables 5.81b/4.67b, Revenue 40.60b/37.88b) |
| GMI: 0.98 (GM 66.42% / 64.81%) |
| AQI: 0.93 (AQ_t 0.52 / AQ_t-1 0.56) |
| SGI: 1.07 (Revenue 40.60b / 37.88b) |
| TATA: -0.01 (NI 11.50b - CFO 12.23b) / TA 69.19b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of PM shares?
As of March 10, 2026, the stock is trading at USD 173.25 with a total of 5,176,320 shares traded.
Over the past week, the price has changed by -5.75%, over one month by -4.72%, over three months by +16.27% and over the past year by +19.11%.
Over the past week, the price has changed by -5.75%, over one month by -4.72%, over three months by +16.27% and over the past year by +19.11%.
Is PM a buy, sell or hold?
Philip Morris International has received a consensus analysts rating of 4.06.
Therefore, it is recommended to buy PM.
- StrongBuy: 7
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the PM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 194.1 | 12% |
| Analysts Target Price | 194.1 | 12% |
PM Fundamental Data Overview March 10, 2026
P/E Trailing = 23.4132
P/E Forward = 20.1613
P/S = 6.5097
P/B = -29.62
P/EG = 1.1027
Revenue TTM = 40.60b USD
EBIT TTM = 15.25b USD
EBITDA TTM = 17.08b USD
Long Term Debt = 45.13b USD (from longTermDebt, last quarter)
Short Term Debt = 3.70b USD (from shortTermDebt, last quarter)
Debt = 48.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 43.96b USD (from netDebt column, last quarter)
Enterprise Value = 308.57b USD (264.60b + Debt 48.84b - CCE 4.87b)
Interest Coverage Ratio = 11.75 (Ebit TTM 15.25b / Interest Expense TTM 1.30b)
EV/FCF = 28.94x (Enterprise Value 308.57b / FCF TTM 10.66b)
FCF Yield = 3.46% (FCF TTM 10.66b / Enterprise Value 308.57b)
FCF Margin = 26.27% (FCF TTM 10.66b / Revenue TTM 40.60b)
Net Margin = 28.34% (Net Income TTM 11.50b / Revenue TTM 40.60b)
Gross Margin = 66.42% ((Revenue TTM 40.60b - Cost of Revenue TTM 13.63b) / Revenue TTM)
Gross Margin QoQ = 65.41% (prev 67.85%)
Tobins Q-Ratio = 4.46 (Enterprise Value 308.57b / Total Assets 69.19b)
Interest Expense / Debt = 0.67% (Interest Expense 326.0m / Debt 48.84b)
Taxrate = 21.77% (674.0m / 3.10b)
NOPAT = 11.93b (EBIT 15.25b * (1 - 21.77%))
Current Ratio = 0.96 (Total Current Assets 24.36b / Total Current Liabilities 25.43b)
Debt / Equity = -4.89 (negative equity) (Debt 48.84b / totalStockholderEquity, last quarter -9.99b)
Debt / EBITDA = 2.57 (Net Debt 43.96b / EBITDA 17.08b)
Debt / FCF = 4.12 (Net Debt 43.96b / FCF TTM 10.66b)
Total Stockholder Equity = -10.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.57% (Net Income 11.50b / Total Assets 69.19b)
RoE = -105.1% (negative equity) (Net Income TTM 11.50b / Total Stockholder Equity -10.94b)
RoCE = 44.60% (EBIT 15.25b / Capital Employed (Equity -10.94b + L.T.Debt 45.13b))
RoIC = 30.55% (NOPAT 11.93b / Invested Capital 39.05b)
WACC = 4.40% (E(264.60b)/V(313.44b) * Re(5.11%) + D(48.84b)/V(313.44b) * Rd(0.67%) * (1-Tc(0.22)))
Discount Rate = 5.11% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.61%
[DCF] Terminal Value 86.38% ; FCFF base≈10.71b ; Y1≈10.75b ; Y5≈11.47b
[DCF] Fair Price = 191.5 (EV 342.10b - Net Debt 43.96b = Equity 298.13b / Shares 1.56b; r=5.90% [WACC]; 5y FCF grow -0.09% → 2.90% )
EPS Correlation: 65.03 | EPS CAGR: 2.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 94.71 | Revenue CAGR: 8.07% | SUE: -0.37 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.15 | Chg7d=-0.001 | Chg30d=+0.037 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-12-31): EPS=8.42 | Chg7d=+0.016 | Chg30d=+0.097 | Revisions Net=+10 | Growth EPS=+11.7% | Growth Revenue=+7.7%
EPS next Year (2027-12-31): EPS=9.19 | Chg7d=-0.002 | Chg30d=+0.094 | Revisions Net=+4 | Growth EPS=+9.1% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 7.9% - Earnings Yield 4.3%)
[Growth] Growth Spread = +2.3% (Analyst 6.0% - Implied 3.7%)
P/E Forward = 20.1613
P/S = 6.5097
P/B = -29.62
P/EG = 1.1027
Revenue TTM = 40.60b USD
EBIT TTM = 15.25b USD
EBITDA TTM = 17.08b USD
Long Term Debt = 45.13b USD (from longTermDebt, last quarter)
Short Term Debt = 3.70b USD (from shortTermDebt, last quarter)
Debt = 48.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 43.96b USD (from netDebt column, last quarter)
Enterprise Value = 308.57b USD (264.60b + Debt 48.84b - CCE 4.87b)
Interest Coverage Ratio = 11.75 (Ebit TTM 15.25b / Interest Expense TTM 1.30b)
EV/FCF = 28.94x (Enterprise Value 308.57b / FCF TTM 10.66b)
FCF Yield = 3.46% (FCF TTM 10.66b / Enterprise Value 308.57b)
FCF Margin = 26.27% (FCF TTM 10.66b / Revenue TTM 40.60b)
Net Margin = 28.34% (Net Income TTM 11.50b / Revenue TTM 40.60b)
Gross Margin = 66.42% ((Revenue TTM 40.60b - Cost of Revenue TTM 13.63b) / Revenue TTM)
Gross Margin QoQ = 65.41% (prev 67.85%)
Tobins Q-Ratio = 4.46 (Enterprise Value 308.57b / Total Assets 69.19b)
Interest Expense / Debt = 0.67% (Interest Expense 326.0m / Debt 48.84b)
Taxrate = 21.77% (674.0m / 3.10b)
NOPAT = 11.93b (EBIT 15.25b * (1 - 21.77%))
Current Ratio = 0.96 (Total Current Assets 24.36b / Total Current Liabilities 25.43b)
Debt / Equity = -4.89 (negative equity) (Debt 48.84b / totalStockholderEquity, last quarter -9.99b)
Debt / EBITDA = 2.57 (Net Debt 43.96b / EBITDA 17.08b)
Debt / FCF = 4.12 (Net Debt 43.96b / FCF TTM 10.66b)
Total Stockholder Equity = -10.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.57% (Net Income 11.50b / Total Assets 69.19b)
RoE = -105.1% (negative equity) (Net Income TTM 11.50b / Total Stockholder Equity -10.94b)
RoCE = 44.60% (EBIT 15.25b / Capital Employed (Equity -10.94b + L.T.Debt 45.13b))
RoIC = 30.55% (NOPAT 11.93b / Invested Capital 39.05b)
WACC = 4.40% (E(264.60b)/V(313.44b) * Re(5.11%) + D(48.84b)/V(313.44b) * Rd(0.67%) * (1-Tc(0.22)))
Discount Rate = 5.11% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.61%
[DCF] Terminal Value 86.38% ; FCFF base≈10.71b ; Y1≈10.75b ; Y5≈11.47b
[DCF] Fair Price = 191.5 (EV 342.10b - Net Debt 43.96b = Equity 298.13b / Shares 1.56b; r=5.90% [WACC]; 5y FCF grow -0.09% → 2.90% )
EPS Correlation: 65.03 | EPS CAGR: 2.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 94.71 | Revenue CAGR: 8.07% | SUE: -0.37 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.15 | Chg7d=-0.001 | Chg30d=+0.037 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-12-31): EPS=8.42 | Chg7d=+0.016 | Chg30d=+0.097 | Revisions Net=+10 | Growth EPS=+11.7% | Growth Revenue=+7.7%
EPS next Year (2027-12-31): EPS=9.19 | Chg7d=-0.002 | Chg30d=+0.094 | Revisions Net=+4 | Growth EPS=+9.1% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 7.9% - Earnings Yield 4.3%)
[Growth] Growth Spread = +2.3% (Analyst 6.0% - Implied 3.7%)